Jun 2026 (Q2 FY26) — Jul 29, 2026
Alkami Technology Q2 FY26 — Strong Revenue Growth and Profitability Exceed Expectations, Bank Market Penetration Continues
Read the full callAlkami Technology (ALKT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Alkami Technology earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 130 | +15.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -5.9 | +8.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -8.9 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$14.23 +3.04% · +$0.42
Performance −38.9% 1Y
1Y: $23.29 on 14 Oct 2025 → $14.23. High $23.81 (24 Oct 2025), low $13.37 (29 Sept 2026).
- Previous close
- $13.81
- 52-week range
- $13.37 – $23.81
- One year
- −38.45%
Overview
- Symbol
- ALKT
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Alkami Technology earnings calls (ALKT)
Financials
What the filings say
Net profit, year on year: +35% (quarter to jun 2026 against jun 2025).
| Line item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 86 | 90 | 98 | 112 | 113 | 121 | 130 |
| Operating profit | -13 | -10 | -9 | -15 | -16 | -13 | -9 | -8 |
| Operating margin | −16.1% | −12.1% | −9.6% | −15.7% | −14.2% | −11.4% | −7.9% | −5.9% |
| Interest | 0 | 0 | 0 | 1 | 3 | 3 | 3 | 2 |
| Profit before tax | -12 | -9 | -8 | -15 | -18 | -15 | -11 | -9 |
| Tax rate | −1.5% | 0.2% | 0.6% | 48.2% | 24.0% | 0.2% | −2.7% | 2.3% |
| Net profit | -12 | -9 | -8 | -8 | -14 | -15 | -11 | -9 |
| EPS ($ per share) | -0.13 | -0.09 | — | -0.08 | -0.13 | -0.14 | — | -0.08 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -264 | -314 | -372 | -435 | -476 | -524 |
| Total liabilities | — | 69 | 92 | 155 | 75 | 80 | 485 |
| Fixed assets | — | 10 | 12 | 14 | 17 | 22 | 27 |
| Total assets | — | 249 | 437 | 489 | 400 | 437 | 847 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -39 | -38 | -29 | -38 | -18 | 19 | 43 |
| Cash from investing | -4 | -27 | -22 | -224 | 34 | 23 | -398 |
| Cash from financing | 30 | 225 | 192 | 61 | -88 | 12 | 324 |
| Net cash flow | -13 | 160 | 141 | -201 | -71 | 53 | -31 |
| Capital expenditure | -4 | -2 | -1 | -1 | -1 | -1 | -2 |
| Free cash flow | -43 | -40 | -30 | -39 | -19 | 17 | 41 |
Insider filings
72 filings between Nov 7, 2025 and Oct 5, 2026.
Open market
decisions to buy or sellPurchases
$254.75M
21 purchases by 3 insiders
Sales
$1.54M
7 sales by 4 insiders
Compensation
not trading decisions- 34
- Award — granted as compensation
- 10
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| GENERAL ATLANTIC GENPAR (BERMUDA), L.P. | $127.32M | — | May 14, 2026 |
| GENERAL ATLANTIC, L.P. | $127.32M | — | May 14, 2026 |
| Shootman Alex | — | $1.12M | Mar 9, 2026 |
| Linebarger Douglas A. | — | $259.6K | Mar 2, 2026 |
| HUDSON CASSANDRA | — | $116.1K | Mar 2, 2026 |
| Payne Joseph P. | $100.2K | — | Mar 11, 2026 |
| Sachdeva Prerna | — | $45.2K | Mar 2, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | SMITH BRIAN R Director | Award | 1,085 | $0 |
| Oct 5, 2026 | Mitchell Steven R Director | Award | 490 | $0 |
| Oct 5, 2026 | FOX JEFFREY H Director | Award | 420 | $0 |
| Oct 5, 2026 | Alvarez Maria Ines Director | Award | 630 | $0 |
| Oct 5, 2026 | Linville Judson C Director | Award | 420 | $0 |
| Sep 8, 2026 | Shootman Alex Chief Executive Officer | Tax withheld | 16,188 | $313.7K |
| Sep 1, 2026 | Shootman Alex Chief Executive Officer | Tax withheld | 5,205 | $101.2K |
| Sep 1, 2026 | Sachdeva Prerna Chief Accounting Officer | Tax withheld | 1,421 | $27.6K |
| Sep 1, 2026 | HUDSON CASSANDRA Chief Financial Officer | Tax withheld | 8,293 | $161.2K |
| Sep 1, 2026 | Linebarger Douglas A. Chief Legal Officer | Tax withheld | 7,381 | $143.5K |
| Aug 7, 2026 | HUDSON CASSANDRA Chief Financial Officer | Award | 52,116 | $0 |
| Jul 5, 2026 | FOX JEFFREY H Director | Award | 457 | $0 |
| Jul 5, 2026 | SMITH BRIAN R Director | Award | 1,180 | $0 |
| Jul 5, 2026 | Alvarez Maria Ines Director | Award | 685 | $0 |
| Jul 5, 2026 | Mitchell Steven R Director | Award | 533 | $0 |
| Jul 5, 2026 | Linville Judson C Director | Award | 457 | $0 |
| Jun 8, 2026 | Shootman Alex Chief Executive Officer | Tax withheld | 16,188 | $256.6K |
| Jun 1, 2026 | Shootman Alex Chief Executive Officer | Tax withheld | 5,205 | $98.6K |
| Jun 1, 2026 | Sachdeva Prerna Chief Accounting Officer | Tax withheld | 1,370 | $26.0K |
| Jun 1, 2026 | Linebarger Douglas A. Chief Legal Officer | Tax withheld | 5,819 | $110.3K |
| Jun 1, 2026 | HUDSON CASSANDRA Chief Financial Officer | Tax withheld | 6,122 | $116.0K |
| May 19, 2026 | KANE CHARLES Director | Award | 11,357 | $0 |
| May 19, 2026 | FOX JEFFREY H Director | Award | 20,323 | $0 |
| May 19, 2026 | SMITH BRIAN R Director | Award | 11,357 | $0 |
| May 19, 2026 | Osnoss Raphael Director | Award | 11,357 | $0 |
| May 19, 2026 | Linville Judson C Director | Award | 20,323 | $0 |
| May 19, 2026 | Morgan Susanna Director | Award | 11,357 | $0 |
| May 19, 2026 | Alvarez Maria Ines Director | Award | 11,357 | $0 |
| May 19, 2026 | Mitchell Steven R Director | Award | 11,357 | $0 |
| May 19, 2026 | Payne Joseph P. Director | Award | 11,357 | $0 |
| May 19, 2026 | Yastine Barbara A. Director | Award | 11,357 | $0 |
| May 14, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 675,000 | $11.13M |
| May 14, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 675,000 | $11.13M |
| May 13, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 550,000 | $9.15M |
| May 13, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 550,000 | $9.15M |
| May 12, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 750,000 | $12.65M |
| May 12, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 750,000 | $12.65M |
| May 6, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 844,772 | $14.05M |
| May 6, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 844,772 | $14.05M |
| May 5, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 700,000 | $11.79M |
| May 5, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 700,000 | $11.79M |
| May 4, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 521,771 | $8.83M |
| May 4, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 521,771 | $8.83M |
| Apr 5, 2026 | Alvarez Maria Ines Director | Award | 674 | $0 |
| Apr 5, 2026 | Mitchell Steven R Director | Award | 524 | $0 |
| Apr 5, 2026 | SMITH BRIAN R Director | Award | 1,160 | $0 |
| Mar 12, 2026 | GENERAL ATLANTIC, L.P. Director | Purchase | 500,000 | $9.16M |
| Mar 12, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 500,000 | $9.16M |
| Mar 11, 2026 | Payne Joseph P. Director | Purchase | 5,500 | $100.2K |
| Mar 11, 2026 | GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Director | Purchase | 900,000 | $16.57M |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for ALKAMI TECHNOLOGY, INC.
Free account. Everything above stays public.
Write why you follow ALKAMI TECHNOLOGY, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading